Glenmark launches Type 2 diabetes drugs in India
The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT<br />
Type 2 Diabetes Drug | 07/07/2022 | By Sudeep Soparkar | 439
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy